Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 08/31/2021 (updated monthly) $1,385.3 (M)
Net Assets - Class C As of 08/31/2021 (updated monthly) $55.8 (M)

Positions As of 08/31/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 08/31/2021 (updated monthly) $36,509.06(M) $55,256.55(M)
P/B RatioAs of 08/31/2021 (updated monthly) 5.15 6.46
P/E Ratio (12-mo Forward)As of 08/31/2021 (updated monthly) 16.15 14.56
Price to Cash FlowAs of 08/31/2021 (updated monthly) 19.58 16.50

Portfolio Details

Asset AllocationAs of 08/31/2021

[name] [value]
Equity 98.99%
Cash & Cash Equivalents 1.01%

Geographic BreakdownAs of 08/31/2021

[name] [value]
United States 90.64%
Denmark 2.52%
Canada 1.96%
Netherlands 1.36%
Switzerland 1.18%
Cash & Cash Equivalents 1.01%
United Kingdom 1.01%
Germany 0.32%

sector breakdownAs of 08/31/2021

[name] [value]
Biotechnology 78.74%
Pharmaceuticals 10.84%
Life Sciences Tools & Services 6.15%
Other Diversified Financial Services 1.33%
Diversified Capital Markets 1.25%
Cash & Cash Equivalents 1.01%
Health Care Services 0.55%
Health Care Facilities 0.12%

TOP TEN HOLDINGSAs of 08/31/2021

Issuer Country Industry % of total
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.83%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.19%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.51%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.48%
HORIZON THERAPEUTICS PLC United States Pharmaceuticals, Biotechnology & Life Sciences 3.81%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.63%
MODERNA INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.62%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.04%
MIRATI THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.98%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.97%

Market Capitalization BreakdownAs of 08/31/2021

[name] [value]
<2.0 Billion 22.14%
2.0-5.0 Billion 16.04%
5.0-10.0 Billion 16.07%
10.0-25.0 Billion 11.11%
>50.0 Billion 33.15%
N/A 1.50%